Novo Nordisk GAAP EPADR of DKK 12.49, revenue of DKK 154.94B; updates FY outlook

2 hours ago 1

Earnings News

Novo Nordisk press release (NVO): 1H GAAP EPADR of DKK 12.49.
Revenue of DKK 154.94B (+16.1% Y/Y).
Sales within Diabetes and Obesity care increased by 16% in Danish kroner to DKK 145.4 billion (18% at CER).
Free cash flow of DKK 33.6

Recommended For You

More Trending News

Read Entire Article